BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Isentress (Raltegravir) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Isentress (Raltegravir)\, from ClinicalTr
 ials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT02140255-968@assetmemo.bio
DTSTAMP:20261121T005623Z
DTSTART;VALUE=DATE:20280131
DTEND;VALUE=DATE:20280201
SUMMARY:Isentress (Raltegravir): Phase 1/2 readout est. (NCT02140255)
DESCRIPTION:Isentress (Raltegravir)\, phase 1/2\, HIV.\nStudy: Very Early I
 ntensive Treatment of Infants Living With HIV to Achieve HIV Remission\nEs
 timated primary completion: 31 January 2028. This is a ClinicalTrials.gov 
 estimate\, not a confirmed readout date\, and it can move.\nDrug page: htt
 ps://assetmemo.bio/drug/raltegravir#upcoming-events\nRegistry record: http
 s://clinicaltrials.gov/study/NCT02140255
URL:https://assetmemo.bio/drug/raltegravir#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
